AmerisourceBergen (ABC) Stock Forecast, Price & News

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

Is AmerisourceBergen a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last twelve months. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AmerisourceBergen stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABC, but not buy additional shares or sell existing shares.
View analyst ratings for AmerisourceBergen or view top-rated stocks.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for AmerisourceBergen.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) announced its earnings results on Wednesday, May, 4th. The company reported $3.22 earnings per share for the quarter, topping the consensus estimate of $2.99 by $0.23. The company had revenue of $57.72 billion for the quarter, compared to analyst estimates of $57.26 billion. AmerisourceBergen had a trailing twelve-month return on equity of 349.46% and a net margin of 0.75%. AmerisourceBergen's quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.53 earnings per share.
View AmerisourceBergen's earnings history.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Wednesday, May 4th. Shareholders of record on Monday, May 16th will be paid a dividend of $0.46 per share on Tuesday, May 31st. This represents a $1.84 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date of this dividend is Friday, May 13th.
View AmerisourceBergen's dividend history.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen pays an annual dividend of $1.84 per share and currently has a dividend yield of 1.23%. AmerisourceBergen has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of AmerisourceBergen is 22.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 15.86% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $10.80-$11.05 for the period, compared to the consensus EPS estimate of $10.79. The company issued revenue guidance of -.

What price target have analysts set for ABC?

7 equities research analysts have issued twelve-month price objectives for AmerisourceBergen's shares. Their forecasts range from $145.00 to $187.00. On average, they anticipate AmerisourceBergen's stock price to reach $164.57 in the next twelve months. This suggests a possible upside of 9.6% from the stock's current price.
View analysts' price targets for AmerisourceBergen or view top-rated stocks among Wall Street analysts.

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:

• Mr. Steven H. Collis, Chairman, Pres & CEO (Age 61, Pay $4.37M) (LinkedIn Profile)
• Mr. James F. Cleary Jr., Exec. VP & CFO (Age 59, Pay $2.17M)
• Ms. Gina K. Clark, Exec. VP and Chief Communications & Admin. Officer (Age 65, Pay $1.72M) (LinkedIn Profile)
• Mr. John G. Chou, Exec. VP and Special Advisor to the Chairman & CEO (Age 66, Pay $2.01M) (LinkedIn Profile)
• Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP & Group Pres (Age 55, Pay $2.31M)
• Mr. Lazarus Krikorian, Sr. VP, Chief Accounting Officer & Corp. Controller (Age 57) (LinkedIn Profile)
• Bennett S. Murphy, Sr. VP of Investor Relations
• Ms. Kathy H. Gaddes, Exec. VP & Chief Compliance Officer (Age 59)
• Ms. Elizabeth S. Campbell, Exec. VP & Chief Legal Officer (Age 47) (LinkedIn Profile)
• Ms. Silvana Battaglia, Exec. VP & Chief HR Officer (Age 55) (LinkedIn Profile)

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

Who are some of AmerisourceBergen's key competitors?

Some companies that are related to AmerisourceBergen include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of ABC's competitors.

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Pfizer (PFE).

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.80%), BlackRock Inc. (7.87%), JPMorgan Chase & Co. (3.54%), State Street Corp (3.31%), Boston Partners (2.23%) and Capital Research Global Investors (1.63%). Company insiders that own AmerisourceBergen stock include Elizabeth S Campbell, Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, John G Chou, Lazarus Krikorian, Robert P Mauch, Silvana Battaglia, Steven H Collis and Walgreens Boots Alliance, Inc.
View institutional ownership trends for AmerisourceBergen.

Which institutional investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Suvretta Capital Management LLC, Beutel Goodman & Co Ltd., JPMorgan Chase & Co., First Trust Advisors LP, Glenview Capital Management LLC, TimesSquare Capital Management LLC, TD Asset Management Inc., and ANTIPODES PARTNERS Ltd. Company insiders that have sold AmerisourceBergen company stock in the last year include Elizabeth S Campbell, Gina Clark, John G Chou, Lazarus Krikorian, Robert P Mauch, Silvana Battaglia, Steven H Collis, and Walgreens Boots Alliance, Inc.
View insider buying and selling activity for AmerisourceBergen or view top insider-selling stocks.

Which institutional investors are buying AmerisourceBergen stock?

ABC stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., Invesco Ltd., Envestnet Asset Management Inc., The Manufacturers Life Insurance Company , Strs Ohio, DekaBank Deutsche Girozentrale, and Goldman Sachs Group Inc..
View insider buying and selling activity for AmerisourceBergen or or view top insider-buying stocks.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $150.18.

How much money does AmerisourceBergen make?

AmerisourceBergen has a market capitalization of $31.46 billion and generates $213.99 billion in revenue each year. The company earns $1.54 billion in net income (profit) each year or $8.199990 on an earnings per share basis.

How many employees does AmerisourceBergen have?

AmerisourceBergen employs 42,000 workers across the globe.

Does AmerisourceBergen have any subsidiaries?

The following companies are subsidiares of AmerisourceBergen: AB Singapore Investments Pte Ltd, AB UK Holdings Ltd, ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group GmbH, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Sourcing LLC, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Physician Networks L.L.C., IntrinsiQ, Lash Group, MWI Veterinary Supply, Network for Medical Communications & Research, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, Wight Nederland Holdco 2 BV, World Courier, World Courier Group S.à r.l., and Xcenda.

When was AmerisourceBergen founded?

AmerisourceBergen was founded in 2001.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at (610) 727-7000, via email at [email protected], or via fax at 800-640-5221.